Dr. Alahmadi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
The James Cancer Hospital and Solove Research Institute
460 W 10th Ave
Columbus, OH 43210Phone+1 216-844-2562
Education & Training
- Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 2017 - 2020
- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 2014 - 2017
- USCDMAS-CR, Master of Advanced Studies in Clinical Research, 2013 - 2014
- King Abdulaziz University College of MedicineClass of 2011, MBBS
Certifications & Licensure
- OH State Medical License 2020 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Ramucirumab and Pembrolizumab for the Treatment of EGFR Mutant Recurrent or Metastatic Non-small Cell Lung Cancer Start of enrollment: 2020 Jun 17
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Evaluating the effect of immune checkpoint inhibitor treatment on chronic obstructive pulmonary disease in lung cancer patients.Anet Greib, Songzhu Zhao, Michelle Ploch, Jonathan Henricks, Robert Easterling
Oncoimmunology. 2025-12-01 - CLO25-080: Outcomes of Extreme Low PD-L1 Expression in Advanced Non-Small Cell Lung Cancer: Implications for Treatment Approaches.Alexander Rudich, Natalie Johns, Songzhu Zhao, Kenneth Chian, Po-Lan Su
Journal of the National Comprehensive Cancer Network. 2025-03-28 - 4 citationsSafety and efficacy outcomes of early cessation of anti-PD1 therapy in patients 80 years or older: A retrospective cohort study.Kylie Fletcher, Alessio Cortellini, Teja Ganta, Roma Kankaria, Haocan Song
Cancer Letters. 2024-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: